Zhen‐Bin Ding
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
Papers in
- Surgery 19
- Cholangiocarcinoma and Gallbladder Cancer Studies 19
- Co-authors
- Jia Fan (73 shared papers)Ying–Hong Shi (50 shared papers)Jian Zhou (47 shared papers)Ai‐Wu Ke (26 shared papers)Shuang–Jian Qiu (21 shared papers)Xiaoying Wang (20 shared papers)Guo‐Ming Shi (15 shared papers)Zhi Dai (20 shared papers)
- Journals
- Hepatology (5 papers)BMC Cancer (4 papers)PLoS ONE (4 papers)Oncotarget (3 papers)Frontiers in Oncology (3 papers)
- Partner nations
- ChinaEthiopiaUnited States
In The Last Decade
Zhen‐Bin Ding
83 papers receiving 4.4k citations
Zhen‐Bin Ding's Hit Papers
Peers
Comparison fields: 5 of 104
- Hepatology 505
- Cancer Research 944
- Oncology 1.1k
- Immunology and Allergy 207
- Immunology 693
Countries citing papers authored by Zhen‐Bin Ding
This map shows the geographic impact of Zhen‐Bin Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhen‐Bin Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhen‐Bin Ding more than expected).
Fields of papers citing papers by Zhen‐Bin Ding
This network shows the impact of papers produced by Zhen‐Bin Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhen‐Bin Ding. The network helps show where Zhen‐Bin Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhen‐Bin Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 240 | |
| 2 | 2013 | 239 | |
| 3 | CD36+ cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor Hit paper breakdown → | 2023 | 237 |
| 4 | 2014 | 197 | |
| 5 | 2013 | 188 | |
| 6 | 2008 | 188 | |
| 7 | 2011 | 162 | |
| 8 | 2011 | 151 | |
| 9 | 2013 | 143 | |
| 10 | 2012 | 138 | |
| 11 | 2008 | 137 | |
| 12 | 2020 | 127 | |
| 13 | 2011 | 125 | |
| 14 | 2018 | 116 | |
| 15 | 2018 | 115 | |
| 16 | 2010 | 111 | |
| 17 | 2017 | 99 | |
| 18 | 2015 | 94 | |
| 19 | 2012 | 89 | |
| 20 | 2014 | 82 |
About Zhen‐Bin Ding
Zhen‐Bin Ding is a scholar working on Surgery, Molecular Biology, Oncology, Hepatology and Epidemiology, having authored 85 papers that have together received 4.4k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (19 papers), Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Autophagy in Disease and Therapy (9 papers), Pancreatic and Hepatic Oncology Research (7 papers), Immune cells in cancer (6 papers), Cancer Mechanisms and Therapy (5 papers), Cancer Genomics and Diagnostics (5 papers) and Gallbladder and Bile Duct Disorders (5 papers). The work is most often cited by research in Hepatology (505 citations), Cancer Research (944 citations), Oncology (1.1k citations), Immunology and Allergy (207 citations) and Immunology (693 citations). Zhen‐Bin Ding has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Jia Fan, Ying–Hong Shi, Jian Zhou, Ai‐Wu Ke, Shuang–Jian Qiu, Xiaoying Wang, Guo‐Ming Shi, Zhi Dai, Yuan‐Fei Peng and Qiang Gao. Their work appears in journals such as Hepatology, BMC Cancer, PLoS ONE, Oncotarget and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.